Search by Drug Name or NDC
NDC 11523-7341-01 MiraLAX 17 g/17g Details
MiraLAX 17 g/17g
MiraLAX is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Bayer HealthCare LLC.. The primary component is POLYETHYLENE GLYCOL 3350.
MedlinePlus Drug Summary
Polyethylene glycol 3350 is used to treat occasional constipation. Polyethylene glycol 3350 is in a class of medications called osmotic laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.
Related Packages: 11523-7341-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Polyethylene Glycol 3350
Product Information
| NDC | 11523-7341 |
|---|---|
| Product ID | 11523-7341_0bb62586-406e-f7e0-e063-6394a90a2b74 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | MiraLAX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Polyethylene Glycol 3350 |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 17 |
| Active Ingredient Units | g/17g |
| Substance Name | POLYETHYLENE GLYCOL 3350 |
| Labeler Name | Bayer HealthCare LLC. |
| Pharmaceutical Class | Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022015 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 11523-7341-01 (11523734101)
| NDC Package Code | 11523-7341-1 |
|---|---|
| Billing NDC | 11523734101 |
| Package | 612 g in 1 BOTTLE, PLASTIC (11523-7341-1) |
| Marketing Start Date | 2007-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |